Safety and Tolerability Study of SHP465 in Children Aged 4 to 12 Years Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD)

Summary

The purpose of the study is to evaluate the long-term safety and tolerability of SHP465 at 6.25 milligram (mg) in children aged 4 to 12 years diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD).

Timeline

Start

2018-01-02

Primary completion

2019-01-19

Completion

2019-01-19

Outcome

Outcome not reported

Stopped: “The study was stopped due to efficacy reasons.”

Drugs

Indications